Trials / Conditions / Advanced Cutaneous Squamous Cell Carcinoma
Advanced Cutaneous Squamous Cell Carcinoma
6 registered clinical trials studyying Advanced Cutaneous Squamous Cell Carcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell NCT05910827 | Hummingbird Bioscience | Phase 1 / Phase 2 |
| Terminated | Study of Ruxolitinib in Solid Organ Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma NCT04807777 | Columbia University | Phase 2 |
| Terminated | Study of IBI318 in Patients With Advanced Cutaneous Squamous Cell Carcinoma NCT04611321 | Innovent Biologics (Suzhou) Co. Ltd. | Phase 1 / Phase 2 |
| Active Not Recruiting | Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer NCT04050436 | Replimune, Inc. | Phase 2 |
| Unknown | Nivolumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma NCT03834233 | Instituto do Cancer do Estado de São Paulo | Phase 2 |
| Completed | Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma NCT02760498 | Regeneron Pharmaceuticals | Phase 2 |